Corcept Therapeutics (CORT) Gross Profit (2012 - 2026)
Corcept Therapeutics' Gross Profit came in at $252.09 million for Q2 2026, up 32.0% from $191 million a year earlier and up 55.6% from the prior quarter.
Powered by 
Analysis
Corcept Therapeutics (CORT) Gross Profit (2012 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Corcept Therapeutics reported Gross Profit of $816.73 million, up 15.9% year-over-year; for FY2025, it came in at $748.43 million, up 12.7% from FY2024.
- Gross Profit has increased in each of the last 13 years, with a five-year compound annual growth rate of 16.5% (FY2020 to FY2025).
- Going back by year, Gross Profit was $664.16 million in FY2024 (+39.6%), $475.89 million in FY2023 (+20.0%), $396.47 million in FY2022 (+9.9%) and $360.7 million in FY2021 (+3.6%).
- The Q2 2026 figure represents the highest quarterly Gross Profit in data going back to Q2 2012.
- Year-over-year, Gross Profit has increased for 21 consecutive quarters, with growth averaging 21.0% over the last eight quarters.
- Across the past five years, year-over-year growth in Gross Profit ran from 4.2% in Q4 2022 to 47.3% in Q3 2024.
- Business Quant data shows CORT's Gross Profit at $162.02 million (Q1 2026), $199.58 million (Q4 2025) and $203.04 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Corcept Therapeutics | 12.56 Bn | 11.12 Bn | 252.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 252.09 Mn |
| Mar 31, 2026 | 162.02 Mn |
| Dec 31, 2025 | 199.58 Mn |
| Sep 30, 2025 | 203.04 Mn |
| Jun 30, 2025 | 191.00 Mn |
| Mar 31, 2025 | 154.81 Mn |
| Dec 31, 2024 | 178.93 Mn |
| Sep 30, 2024 | 179.68 Mn |
| Jun 30, 2024 | 161.27 Mn |
| Mar 31, 2024 | 144.27 Mn |
| Dec 31, 2023 | 133.53 Mn |
| Sep 30, 2023 | 121.96 Mn |
| Jun 30, 2023 | 116.14 Mn |
| Mar 31, 2023 | 104.27 Mn |
| Dec 31, 2022 | 101.58 Mn |
| Sep 30, 2022 | 100.39 Mn |
| Jun 30, 2022 | 102.07 Mn |
| Mar 31, 2022 | 92.44 Mn |
| Dec 31, 2021 | 97.47 Mn |
| Sep 30, 2021 | 94.86 Mn |
API Access
Corcept Therapeutics Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=CORT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "CORT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=CORT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();